Response to Anti-TNF Linked to CV Risk in RA

Response to Anti-TNF Linked to CV Risk in RA

Tumor necrosis factor (TNF) inhibitor treatment of rheumatoid arthritis (RA) that successfully reduces RA disease activity also appears to improve cardiovascular (CV) risk in this population. Compared with European League Against Rheumatism (EULAR) …

(Visited 1 times, 1 visits today)
6
Like
Save

Comments

Comments are disabled for this post.